Overview

Medical diagnosis studies how to combine symptoms, records, laboratory tests, medical images, physiological signals, and molecular data to identify disease and support clinical decisions. Methods range from conventional machine learning and deep models such as CNNs and graph networks to multimodal foundation models, retrieval-augmented language models, and agents that ask questions or request tests as evidence accumulates. Systems are evaluated on tasks including image and signal classification, electronic-record prediction, and conversational diagnosis, using resources such as MIMIC and ADNI alongside disease-specific and external-site cohorts. A central challenge is that strong benchmark results may not transfer to real clinics, where data are incomplete or shifted and models must provide calibrated, evidence-grounded recommendations without worsening bias or unsafe decisions.

Latest papers

277 papers15 papers in the last four weeks, down 50% on the four weeks before. 0.1% of all new papers.

Jul 4, 2025

Detecting and explaining clinical-omics inconsistencies to improve patient cohort stratification: an application to Parkinson's disease

Discrepancies between clinical diagnoses and omics profiles within a characterized cohort may reflect misdiagnosis, hidden subgroups or prodromal disease states. We propose MLASDO, a tool to detect and characterize such discrepancies before downstream analyses. MLASDO (1) detects outliers using two unsupervised methods, thereby flagging potential poor-quality samples; and (2) identifies and characterizes anomalous samples (ASs), i.e., individuals whose molecular profile resembles the opposite clinical class. We applied MLASDO to the Parkinson's Progression Markers Initiative (PPMI) and Parkinson's Disease Biomarkers Program (PDBP) Parkinson's disease (PD) cohorts. In PPMI, it detected 26 outliers and 12 ASs: 5 anomalous healthy controls (AHCs) and 7 anomalous PD cases (APDs). AHCs exhibited higher cerebrospinal fluid (CSF) A\b{eta}1-42 levels than controls (P < 0.0396), suggesting resistance to cognitive decline. AHC-specific genes were enriched for the MAPK pathway (P<0.0145), implicated in PD pathogenesis. One AHC later received a different neurological disorder, three months after enrollment. In PDBP, it identified 10 outliers and 8 ASs: 2 AHCs and 6 APDs. One AHC exhibited 24 clinical features consistent with a PD-like phenotype, including severe motor impairment. Results are compiled in an interactive report for inspection and querying, highlighting clinically meaningful individuals otherwise overlooked in conventional analyses.
Jun 25, 2025

X-SiT: Inherently Interpretable Surface Vision Transformers for Dementia Diagnosis

Interpretable models are crucial for supporting clinical decision-making, driving advances in their development and application for medical images. However, the nature of 3D volumetric data makes it inherently challenging to visualize and interpret intricate and complex structures like the cerebral cortex. Cortical surface renderings, on the other hand, provide a more accessible and understandable 3D representation of brain anatomy, facilitating visualization and interactive exploration. Motivated by this advantage and the widespread use of surface data for studying neurological disorders, we present the eXplainable Surface Vision Transformer (X-SiT). This is the first inherently interpretable neural network that offers human-understandable predictions based on interpretable cortical features. As part of X-SiT, we introduce a prototypical surface patch decoder for classifying surface patch embeddings, incorporating case-based reasoning with spatially corresponding cortical prototypes. The results demonstrate state-of-the-art performance in detecting Alzheimer's disease and frontotemporal dementia while additionally providing informative prototypes that align with known disease patterns and reveal classification errors.
May 21, 2025

Benchmarking Classification Tasks of Chest X-ray AI Across Multinational Public and Private Datasets: a retrospective diagnostic accuracy study

Chest X-ray (CXR) AI models are increasingly proposed for triage, screening, and rule-out, where the operating point is fixed to miss few abnormalities. Most evaluations instead report threshold-free discrimination on a few public benchmarks, leaving clinically usable performance and generalisability to unseen institutional cohorts poorly characterised. We retrospectively evaluated 10 published CXR classification models on 12 datasets from six countries: seven public benchmarks and five institutional cohorts from China, Japan, and Germany. Models spanned convolutional networks, vision-language models, a question-answering foundation model, and a repurposed encoder. Only image-level classification was assessed; segmentation, detection, and report generation were out of scope. Source labels were harmonised to a common vocabulary. The primary outcome was specificity at 95% sensitivity; PPV at 95% sensitivity and AUROC were secondary outcomes. Estimates weighted each diagnostic task equally, with 95% CIs. MAVL and MedKLIP had the highest overall specificity at 95% sensitivity (0.37 [95% CI 0.31-0.44] and 0.37 [0.30-0.44]) and kept that ranking on tasks evaluable for every model. Their PPV was 0.18 (0.13-0.24) and 0.19 (0.13-0.25): most flagged examinations would be false positives. Specificity was lower on institutional cohorts than on public benchmarks for most models, by 0.13 for MAVL, 0.15 for DenseNet, and 0.09 for MedKLIP. No model was best for every finding, country, lesion extent, or prevalence stratum; specificity fell from 0.34 for diffuse to 0.15 for focal findings. At 95% sensitivity, the best current models clear only about a third of truly negative examinations, and public-benchmark performance overstates what they achieve on unseen institutional data. Operating-point-aware evaluation and external validation on institutional cohorts should precede deployment.
Feb 3, 2025

A Wearable Device Dataset for Mental Health Assessment Using Laser Doppler Flowmetry and Fluorescence Spectroscopy Sensors

Mental health problems such as stress, anxiety, and depression affect millions of people worldwide. These conditions are usually assessed using questionnaires, which rely on how people describe their own feelings. In this study, we explore whether a wearable device can help measure mental health using physical signals from the body. The device records small changes in blood flow and tissue activity from the fingertip. We collected data from 132 adults across 19 countries and compared these signals with mental health questionnaire results. We found that patterns in blood flow and tissue activity are linked to stress-related symptoms. This approach may help develop new tools for simple, non-invasive mental health monitoring in everyday life. Code and datasets are publicly available: https://github.com/leduckhai/Wearable_LDF-FS
Aug 5, 2024

Heterogeneous Graph Attention Network With Multimodal Feature Selection for Cancer Multiomics Integration

The increase in high-dimensional multiomics data demands advanced integration models to capture the complexity of human diseases. Graph-based deep learning integration models, despite their promise, struggle with small patient cohorts and high-dimensional features, often applying independent feature selection without modeling relationships among omics. Furthermore, conventional graph-based omics models focus on homogeneous graphs, lacking multiple types of nodes and edges to capture diverse structures. We introduce a Heterogeneous Graph ATtention network for omics integration (HeteroGATomics) to improve cancer diagnosis. HeteroGATomics performs multimodal feature selection through a multi-agent system, creating dedicated networks of feature and patient similarity for each omics modality. These networks are then combined into one heterogeneous graph for learning holistic omics-specific representations and integrating predictions across modalities. Experiments on three cancer multiomics datasets show that HeteroGATomics outperforms baseline methods across most evaluation metrics in cancer diagnosis. External validation on an independent breast cancer cohort further demonstrates its generalizability, where HeteroGATomics outperforms graph-based multiomics integration methods across evaluation metrics. Moreover, HeteroGATomics enhances interpretability by identifying important biomarkers contributing to the diagnosis outcomes.
Mar 7, 2024

Few shot chain-of-thought driven reasoning to prompt LLMs for open ended medical question answering

In this paper, we propose a modified version of the MedQA-USMLE dataset, named MEDQA-OPEN, which contains open-ended medical questions without options to mimic clinical scenarios, along with clinician-approved reasoned answers. Additionally, we implement a prompt driven by Chain of Thought (CoT) reasoning, CLINICR, to mirror the prospective process of incremental reasoning, reaching a correct response to medical questions. We empirically demonstrate how CLINICR outperforms the state-of-the-art 5-shot CoT-based prompt (Liévin et al., 2022). We also present an approach that mirrors real-life clinical practice by first exploring multiple differential diagnoses through MCQ-CLINICR and subsequently narrowing down to a final diagnosis using MCQ-ELIMINATIVE. Finally, emphasizing the importance of response verification in medical settings, we utilize a reward model mechanism, replacing the elimination process performed by MCQ-ELIMINATIVE.
Sep 30, 2023

Unveiling the Unborn: Advancing Fetal Health Classification through Machine Learning

Fetal health classification is a critical task in obstetrics, enabling early identification and management of potential health problems. However, it remains challenging due to data complexity and limited labeled samples. This research paper presents a novel machine-learning approach for fetal health classification, leveraging a LightGBM classifier trained on a comprehensive dataset. The proposed model achieves an impressive accuracy of 98.31% on a test set. Our findings demonstrate the potential of machine learning in enhancing fetal health classification, offering a more objective and accurate assessment. Notably, our approach combines various features, such as fetal heart rate, uterine contractions, and maternal blood pressure, to provide a comprehensive evaluation. This methodology holds promise for improving early detection and treatment of fetal health issues, ensuring better outcomes for both mothers and babies. Beyond the high accuracy achieved, the novelty of our approach lies in its comprehensive feature selection and assessment methodology. By incorporating multiple data points, our model offers a more holistic and reliable evaluation compared to traditional methods. This research has significant implications in the field of obstetrics, paving the way for advancements in early detection and intervention of fetal health concerns. Future work involves validating the model on a larger dataset and developing a clinical application. Ultimately, we anticipate that our research will revolutionize the assessment and management of fetal health, contributing to improved healthcare outcomes for expectant mothers and their babies.